Demant A/S (Demant) is a medical device company. The company is involved in providing hearing care, delivering hearing aids, and offering diagnostic equipment and services to hearing care professionals and users globally. The company serves customers in more than 130 countries, with direct sales through local sales organizations and hearing care clinics in over 30 countries. The remaining markets are serviced by distributors.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Demant's R&D arm focuses on emphasizing technological advancements in its R&D activities. The company invests in R&D for both Hearing Aids and Diagnostics, aiming to deliver superior technological solutions to the market. Collaboration between R&D functions across business areas is prioritized to enhance value, and the company maintains a resilient manufacturing setup to ensure supply chain agility and resilience. The main R&D sites of Demant are located in Denmark, Poland, and Malaysia, with additional smaller R&D sites in other countries. These units are responsible for driving technological innovation and core technology development within the company. As of December 2025, the company had more than 2,600 patents and more than 1,200 registered trademarks. In FY2025, the company spent DKK1,401 million on R&D, which as a percentage of revenue, stood at 6.1%.